Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Incidence of Lung Cancer: A Retrospective Study

Introduction: Angiotensin-converting enzyme inhibitor (ACEI) and angiotensin II receptor blockers (ARBs) are taken as the first treatment option for hypertensive patients. The various global trials have suggested that ACEIs and ARBs may increase risk of lung cancer; however, the results are contradi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cureus
Hauptverfasser: Kumar, Pardeep, Kumar, Vinod, Murlidhar, Manish, Fatima, Aliya, Jahangir, Maha, Khalid, Dua, Memon, Muhammad Khizar, Memon, Sidra, Kumar, Besham
Format: Artigo
Sprache:Inglês
Veröffentlicht: Cureus 2021
Schlagworte:
Cardiology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8168993/
https://ncbi.nlm.nih.gov/pubmed/34094750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.14788
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge